Dr Bill Renwick
Clinical (Fellow)
Department of Medicine
2 Scholarly works
0 Projects
HIGHLIGHTS
2025
Conference Proceedings
Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)
DOI: 10.1182/blood-2025-40392017
Journal article
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
DOI: 10.3324/haematol.2016.154039